About this Research Topic
This collection aims to showcase cutting-edge research, reviews, and clinical studies exploring novel pharmacological approaches to treating a wide range of urogenital conditions. These include, but are not limited to, overactive bladder, urinary incontinence, benign prostatic hyperplasia, erectile dysfunction, pelvic organ prolapses, and lower urinary tract symptoms associated with diabetes and other systemic diseases.
The field of pharmacological treatment strategies for urogenital disorders is rapidly evolving, with new drug classes, targeted therapies, and innovative treatment modalities emerging. This topic will provide a platform for disseminating the latest research that can shape the future of treatment for these conditions. We welcome submissions from a broad range of disciplines, including urology, pharmacology, gynecology, endocrinology, and reproductive health, to foster interdisciplinary collaboration and knowledge exchange.
Given the rapid growth of the elderly population globally and the increasing prevalence of patients with serious comorbidities in cardiovascular, respiratory, and other systems who may not be suitable candidates for surgery and anesthesia, pharmacological treatments are not just a promising option but may indeed be the best choice for many patients with urogenital disorders.
We invite submissions in various formats, including:
1. Original research articles on new pharmacological agents, mechanisms of action, and therapeutic targets
2. Clinical trials assessing the efficacy and safety of emerging or repurposed drugs
3. Review articles summarizing the current landscape of pharmacological treatments and highlighting future directions
4. Translational research focusing on developing new pharmacotherapies based on molecular, genetic, and cellular insights
5. Case studies demonstrating unique or groundbreaking therapeutic approaches
6. Meta-analyses and systematic reviews evaluating the effectiveness of existing treatments and identifying knowledge gaps
We particularly encourage submissions that explore novel pharmacological interventions, combination therapies, and personalized medicine approaches. Papers focusing on overcoming resistance to current treatments or improving patient compliance and quality of life are especially welcome.
The field of pharmacological treatment strategies for urogenital disorders is rapidly evolving, with new drug classes, targeted therapies, and innovative treatment modalities emerging. This topic will provide a platform for disseminating the latest research that can shape the future of treatment for these conditions. We welcome submissions from a broad range of disciplines, including urology, pharmacology, gynecology, endocrinology, and reproductive health, to foster interdisciplinary collaboration and knowledge exchange.
Given the rapid growth of the elderly population globally and the increasing prevalence of patients with serious comorbidities in cardiovascular, respiratory, and other systems who may not be suitable candidates for surgery and anesthesia, pharmacological treatments are not just a promising option but may indeed be the best choice for many patients with urogenital disorders.
We invite submissions in various formats, including:
1. Original research articles on new pharmacological agents, mechanisms of action, and therapeutic targets
2. Clinical trials assessing the efficacy and safety of emerging or repurposed drugs
3. Review articles summarizing the current landscape of pharmacological treatments and highlighting future directions
4. Translational research focusing on developing new pharmacotherapies based on molecular, genetic, and cellular insights
5. Case studies demonstrating unique or groundbreaking therapeutic approaches
6. Meta-analyses and systematic reviews evaluating the effectiveness of existing treatments and identifying knowledge gaps
We particularly encourage submissions that explore novel pharmacological interventions, combination therapies, and personalized medicine approaches. Papers focusing on overcoming resistance to current treatments or improving patient compliance and quality of life are especially welcome.
Keywords: urogenital disorders, pharmacology, urogenital conditions
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
